Phosphonoformate was found to be an inhibitor of the deoxyribonucleic acid polymerase induced by the herpesvirus of turkeys. The apparent inhibition constants were 1 to 3 ,uM. Phosphonoformate was also able to block the replication in cell culture of Marek's disease herpesvirus, the herpesvirus of turkeys, and herpes simplex virus. It was as effective as phosphonoacetate. Phosphonoformate was not an effective inhibitor of a phosphonoacetate-resistant mutant of the herpesvirus of turkeys nor of its induced deoxyribonucleic acid polymerase.
Phosphonoformate was found to be an inhibitor of the deoxyribonucleic acid polymerase induced by the herpesvirus of turkeys. The apparent inhibition constants were 1 to 3 ,uM. Phosphonoformate was also able to block the replication in cell culture of Marek's disease herpesvirus, the herpesvirus of turkeys, and herpes simplex virus. It was as effective as phosphonoacetate. Phosphonoformate was not an effective inhibitor of a phosphonoacetate-resistant mutant of the herpesvirus of turkeys nor of its induced deoxyribonucleic acid polymerase.
Phosphonoacetate is an effective inhibitor of the replication of herpesviruses (11, 13, 23, 25) . The inhibition of herpesvirus replication is through an effect on the viral-induced deoxyribonucleic acid (DNA) polymerase (9, (14) (15) (16) 18) . In animal model studies, the efficacy of phosphonoacetate as an antiherpesvirus drug has been clearly demonstrated (7, 8, 12) . Its clinical use, however, may be limited because it is somewhat toxic to test animals and because it is accumulated in bone (4) .
Other phosphonate compounds are of interest as inhibitors of herpesvirus replication because they might exhibit an improved therapeutic ratio over phosphonoacetate either by being more effective inhibitors of virus replication or by being less toxic to animals. These compounds are also of interest at the enzymological level for the information that they might provide about the binding site on the herpesvirus-induced DNA polymerase. Consequently, using as an assay procedure the ability to inhibit the herpesvirus-induced DNA polymerase or the ability to block herpesvirus replication in cell culture or in animals, many other phosphonates have been looked at (10, 13, 14, 23 with NaOH, and the product was recrystallized several times from water to give trisodium phosphonoformate hexahydrate. Phosphorus analysis (1) for CNa3O5P .6H20 gave a molecular weight of 299 (in theory, 300). The '3C-nuclear magnetic resonance proton-decoupled spectrum gave a resonance at 180 ppm (doublet, Jp-c = 229.3 Hz). Trisodium phosphonoformate was further characterized by descending paper chromatography with the following solvent systems: (i) isopropyl alcohol-water-concentrated ammonia (7:2:1), Rf = 0.03; (ii) methanol-water-concentrated ammonia (6:1:3), Rf = 0.63; (iii) ethanol-i M ammonium acetate, pH 7.5 (5:2), Rf = 0.06. The chromatograms were sprayed as described by Bandurski and Axelrod (2) , and only a single blue spot was detected with each solvent system. Virus strains. Marek's disease herpesvirus strain GA (MDHV) (19) was propagated in priiftary duck embryo fibroblasts as previously described (24) . HVT strain FC-126 (HVT,t) (28) and a phosphonoacetate resistant mutant of this strain (HVTp,X) (L. F. Lee, K. Nazerian, R. Witter, S. Leinbach, and J. Boezi, manuscript in preparation) were also propagated in primary duck embryo fibroblasts as previously described. The HSV type 1 used was the MP strain (20) adapted to duck embryo fibroblasts.
Assessment of phosphonate effect on herpesvirus replication. Triplicate duck embryo fibroblasts culture samples were inoculated with MDHV and incubated with various concentrations of phosphonoformate or phosphonoacetate according to the following regimen: with 0.035 mM phosphonate, cultures were inoculated with 50, 100, 500, and 1,000 plaque-forming units (PFU); with 0.07 mM phosphonate, cultures were inoculated with 100, 500, 1,000, and 5,000 PFU; at 0.14 mM phosphonate, with 5,000 and 10,000 PFU; and at 0.28 mM, with 50,000 and 100,000, and 500,000 PFU. Cultures were incubated, and plaques were counted 6 or 7 days postinfection. Relative Preparation of HVT-mduced DNA polymerase. Both HVT,t and HVTpa were treated in an identical manner. The preparation and growth of duck embryo fibroblasts and infection with virus was as previously described (3) . The partial purification of the HVT-induced DNA polymerase was from the nuclear fraction of infected cells by phosphocellulose chromatography as described by Leinbach et al. (14) . The specific enzymatic activity of the preparation used in the kinetic studies reported here was about 1,000 nmol of deoxynucleoside monophosphate incorporated into DNA/30 min per mg of protein. This enzyme fraction, when tested using the standard assay conditions for DNA polymerization, contained no detectable deoxyribonuclease activity, deoxyribonucleoside triphosphatase activity, or inorganic pyrophosphatase activity. The kinetic experiment with HVTwt-induced DNA polymerase was also performed with a more highly purified preparation which had been purified by phosphocellulose and hydroxylapatite chromatography. No differences in the results were seen.
Inhibition patterns. Inhibition patterns and kinetic constants were defined according to the nomenclature of Cleland (5, 6) . The data for the double reciprocal plots were evaluated using a computer program based on the method of Wilkinson (27) . For evaluation of the apparent inhibition constants, replots of the intercepts and slopes of the double reciprocal plots were analyzed by the method of least squares. RESULTS Phosphonoformate inhibition of the DNA polymerization reaction catalyzed by HVTwt-induced DNA polymerase. In the course of a study examining phosphonate compounds for their ability to inhibit the herpesvirus-induced DNA polymerase, it was discovered that phosphonoformate was an effective inhibitor of the HVTwt-induced DNA polymerase. The addition of 2 to 3 uM phosphonoformate to the standard assay mixture resulted in a decrease in the rate of the DNA polymerization reaction by about 50%. The inhibition patterns produced by phosphonoformate were examined, and as shown in Fig. 1 (Fig. 2) . The addition of 0.06 to 0.07 mM of either phosphonate to the culture medium brought about a 50% reduction in the number of plaques observed. Essentially no plaques were observed at concentrations above 0.3 mM.
Phosphonoformate and phosphonoacetate also exhibited a parallel ability to block the replication of MDHV. The addition of either phosphonate to a final concentration of about 0.02 mM brought about a 50% reduction in the number of plaques produced. Either phosphonate at 0.14 mM reduced the number of plaques by more than three orders of magnitude (Fig.  3) At concentrations up to 0.55 mM, phosphonoformate had no obvious cytotoxic effect on the growth of normal duck embryo fibroblasts. The treated cells formed a confluent monolayer in the usual time, and maintenance of the monolayer was normal.
In the above studies, phosphonoformate was an effective inhibitor of the replication of MDHV, HVT,t, and HSV in cell culture. Phosphonoformate, however, was not an effective inhibitor of the replication of HVTpa in cell culture. As seen in Fig. 2 , the replication of HVTpa is less sensitive to phosphonoformate than is the replication of HVTwt. This indicates that the mutation to phosphonoacetate resistance also leads to phosphonoformate resistance and suggests that the DNA polymerase of HVTpa is altered so as to be less sensitive to phosphonoformate as well as phosphonoacetate.
Phosphonoformate inhibition of the DNA polymerization reaction catalyzed by the HVTpa-induced DNA polymerase. Indeed, phosphonoformate, like phosphonoacetate, was not an effective inhibitor of the DNA polymerase of this phosphonoacetate-resistant mutant. With the four dNTP's as the variable substrate, phosphonoformate again gave linear noncompetitive inhibition (Fig. 4) 
